Breaking News, Collaborations & Alliances

Qualigen Enters Manufacturing Agreement with Hande Sciences

CDMO Hande will provide process development and scale-up batches of material for GLP toxicology studies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Qualigen Therapeutics, a life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, has partnered with China-based Hande Sciences to conduct manufacturing scale-up activities to support the company’s IND-enabling good laboratory practice (GLP) studies for its lead therapeutic program, QN-302. The company has chosen Hande for its capabilities in performing custom synthesis and proces...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters